Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NAVN IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Navan, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 24 Deadline in Securities Class Action - NAVN

accessnewswire.com
NAVN

Rosen Law Firm Encourages Masonglory Ltd. Investors to Inquire About Securities Class Action Investigation – MSGY

businesswire.com
MSGY

Century Aluminum Commences Expanded Production at Mt. Holly Smelter

globenewswire.com
CENX

TechCreate Investor News: Rosen Law Firm Encourages TechCreate Group Ltd. Investors to Inquire About Securities Class Action Investigation – TCGL

businesswire.com
TCGL

Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year

globenewswire.com
SNWV

Nelnet Campus Commerce to Be Featured on Now We Know! with Steve Guttenberg - Airing April 18 on CNBC

prnewswire.com
NNI

WaFd Announces Quarterly Earnings Per Share Of $0.82

businesswire.com
WAFD

Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year

globenewswire.com
SNWV

Robbins LLP Encourages NKTR Stockholders to Contact The Firm For Information About The Class Action Against Nektar Therapeutics

accessnewswire.com
NKTR

Robbins LLP Encourages NKTR Stockholders to Contact The Firm For Information About The Class Action Against Nektar Therapeutics

accessnewswire.com
NKTR
View all news →